zen labs tirzepatide The benefits are stacking up! Zepbound® (generic name tirzepatide) is a prescription, once-weekly injectable medication approved by the FDA for chronic weight management in adults with obesity or those who are overweight Eli Lilly Gets FDA Approval

The SURMOUNT-4 trial demonstrated that participants who discontinued tirzepatide after initial weight loss regained significant weight (approximately 14% regain over 52 weeks following randomized withdrawal), while those continuing treatment maintained their weight loss, confirming ongoing medication efficacy

Depending on timing of exposure, additional monitoring throughout pregnancy might be recommended

Missed Dose : Administer within 5 days of the missed dose

It binds itself to toxins, heavy metals, and metabolic byproducts, allowing them to be safely and efficiently excreted

These references describe the nutritional roles of the individual components